Urinary connective tissue growth factor increases far earlier than histopathological damage and functional deterioration in early chronic renal allograft injury

References

• Zaltzman JS, Boucher A, Busque S, Halloran PF, Landsberg DN, McAlister VC, et al. A prospective 3-yr evaluation of tacrolimus-based immunosuppressive therapy in immunological high risk renal allograft recipients. Clin Transplant 2005; 19: 26–32
   PubMed Web of Science ®Google Scholar
• Grinyo JM, Cruzado JM. Mycophenolate mofetil and sirolimus combination in renal transplantation. Am J Transplant 2006; 6: 1991–9
   PubMed Web of Science ®Google Scholar
• Nankivell BJ, Chapman JR. Chronic allograft nephropathy: current concepts and future directions. Transplantation 2006; 81: 643–54
   PubMed Web of Science ®Google Scholar
• Morales JM. Immunosuppressive treatment and progression of histologic lesions in kidney allografts. Kidney Int Suppl 2005; 99: S124–30
   Google Scholar
• Banasik M, Klinger M. Chronic allograft nephropathy – immunologic and nonimmunologic factors. Ann Transplant 2006; 11: 7–10
   PubMedGoogle Scholar
• Chapman JR, O'Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol 2005; 16: 3015–26
   PubMed Web of Science ®Google Scholar
• Joosten SA, Sijpkens YW, van Kooten C, Paul LC. Chronic renal allograft rejection: pathophysiologic considerations. Kidney Int 2005; 68: 1–13
   PubMed Web of Science ®Google Scholar
• Freese P, Svalander CT, Molne J, Norden G, Nyberg G. Chronic allograft nephropathy – biopsy findings and outcome. Nephrol Dial Transplant 2001; 16: 2401–6
   PubMed Web of Science ®Google Scholar
• Moreso F, Ibernon M, Goma M, Carrera M, Fulladosa X, Hueso M, et al. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006; 6: 747–52
   PubMed Web of Science ®Google Scholar
• Chapman JR. Longitudinal analysis of chronic allograft nephropathy: clinicopathologic correlations. Kidney Int Suppl 2005; 99: S108–12
   Google Scholar
• Legendre C, Thervet E, Skhiri H, Mamzer-Bruneel MF, Cantarovich F, Noel LH, et al. Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients. Transplantation 1998; 65: 1506–9
   PubMed Web of Science ®Google Scholar
• Cheng O, Thuillier R, Sampson E, Schultz G, Ruiz P, Zhang X, et al. Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis. Am J Transplant 2006; 6: 2292–306
   PubMed Web of Science ®Google Scholar
• Lessan-Pezeshki M, Amirzargar A, Fathi A, Khatami MR, Einollahi B, Pourfarziani V, et al. Value of pretransplantation cytokine profiles for predicting acute rejection in renal transplant recipients. Transplant Proc 2005; 37: 2982–4
   PubMedGoogle Scholar
• Sezer S, Akcay A, Ozdemir FN, Kulah E, Arat Z, Haberal M. Post-transplant C-reactive protein monitoring can predict chronic allograft nephropathy. Clin Transplant 2004; 18: 722–5
   PubMed Web of Science ®Google Scholar
• Fernandez-Fresnedo G, Plaza JJ, Sanchez-Plumed J, Sanz-Guajardo A, Palomar-Fontanet R, Arias M. Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation. Nephrol Dial Transplant 2004; 19(Suppl 3:iii)47–51
   PubMedGoogle Scholar
• Shi Y, Wang W, Tu Z, Zhang L, Qiu J, Li Q, et al. The C-terminal peptide of connective tissue growth factor blocks the full molecule binding to tubular epithelial cell. Transplant Proc 2006; 38: 2187–9
   PubMed Web of Science ®Google Scholar
• Inkinen K, Soots A, Krogerus L, Loginov R, Bruggeman C, Lautenschlager I. Cytomegalovirus enhances expression of growth factors during the development of chronic allograft nephropathy in rats. Transpl Int 2005; 18: 743–9
   PubMed Web of Science ®Google Scholar
• Burns WC, Twigg SM, Forbes JM, Pete J, Tikellis C, Thallas-Bonke V, et al. Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol 2006; 17: 2484–94
   PubMed Web of Science ®Google Scholar
• Forino M, Torregrossa R, Ceol M, Murer L, Vella MD, Prete DD, et al. TGFβ1 induces epithelial–mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture. Int J Exp Pathol 2006; 87: 197–208
   PubMed Web of Science ®Google Scholar
• Kiss E, Adams J, Grone HJ, Wagner J. Isotretinoin ameliorates renal damage in experimental acute renal allograft rejection. Transplantation 2003; 76: 480–9
   PubMed Web of Science ®Google Scholar
• Kamada N. A description of cuff techniques for renal transplantation in the rat. Use in studies of tolerance induction during combined liver grafting. Transplantation 1985; 39: 93–5
   PubMed Web of Science ®Google Scholar
• Solez, K, Benediktsson, H, Cavallo, T, Croker, B, Demetris, AJ, Drachenberg, C, , et al. Report of The Third Banff Conference on Allograft Pathology (July 20–24, 1995) on classification and lesion scoring in renal allograft pathology. Transplant Proc 1996; 28: 441–4
   PubMed Web of Science ®Google Scholar
• White C, Akbari A, Hussain N, Dinh L, Filler G, Lepage N, Knoll GA. Estimating glomerular filtration rate in kidney transplantation: a comparison between serum creatinine and cystatin C-based methods. J Am Soc Nephrol 2005; 16: 3763–3770
   PubMed Web of Science ®Google Scholar
• Koch J. Primed in situ labeling. Methods Mol Biol 2002; 204: 77–84
   PubMedGoogle Scholar
• Coullin P, Roy L, Pellestor F, Candelier JJ, Bed-Hom B, Guillier-Gencik Z, et al. PRINS, the other in situ DNA labeling method useful in cellular biology. Am J Med Genet 2002; 107: 127–35
   PubMed Web of Science ®Google Scholar
• Wachtel SS, Tharapel AT. FISH and PRINS: competing or complementary technologies?. Am J Med Genet 2002; 107: 97–8
   PubMed Web of Science ®Google Scholar
• Li H, McGuire TC, Muller-Doblies UU, Crawford TB. A simpler, more sensitive competitive inhibition enzyme-linked immunosorbent assay for detection of antibody to malignant catarrhal fever viruses. J Vet Diagn Invest 2001; 13: 361–4
   PubMed Web of Science ®Google Scholar
• Leask A, Abraham DJ. The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol 2003; 81: 355–63
   PubMed Web of Science ®Google Scholar
• Leask A, Abraham DJ. TGF-β signaling and the fibrotic response. FASEB J 2004; 18: 816–27
   PubMed Web of Science ®Google Scholar
• Leask A. Transcriptional profiling of the scleroderma fibroblast reveals a potential role for connective tissue growth factor (CTGF) in pathologic fibrosis. Keio J Med 2004; 53: 74–7
   PubMedGoogle Scholar
• Qi W, Twigg S, Chen X, Polhill TS, Poronnik P, Gilbert RE, et al. Integrated actions of transforming growth factor-β1 and connective tissue growth factor in renal fibrosis. Am J Physiol Renal Physiol 2005; 288: F800–9
   PubMed Web of Science ®Google Scholar
• Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006; 69: 213–7
   PubMed Web of Science ®Google Scholar
• Rastaldi MP, Ferrario F, Giardino L, Dell'Antonio G, Grillo C, Grillo P, et al. Epithelial–mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 2002; 62: 137–46
   PubMed Web of Science ®Google Scholar
• Zeisberg M, Kalluri R. The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med 2004; 82: 175–81
   PubMed Web of Science ®Google Scholar
• Badid C, Desmouliere A, Babici D, Hadj-Aissa A, McGregor B, Lefrancois N, et al. Interstitial expression of alpha-SMA: an early marker of chronic renal allograft dysfunction. Nephrol Dial Transplant 2002; 17: 1993–8
   PubMed Web of Science ®Google Scholar
• Patel S, Mason RM, Suzuki J, Imaizumi A, Kamimura T, Zhang Z. Inhibitory effect of statins on renal epithelial-to-mesenchymal transition. Am J Nephrol 2006; 26: 381–7
   PubMed Web of Science ®Google Scholar